LSI Industries (LYTS) Insider Notice: 500k Shares Proposed Sale

Rhea-AI Filing Summary

Form 144 Notice — LSI Industries Inc (LYTS)

This Form 144 records a proposed sale of 500,000 shares of common stock to be executed on 09/09/2025 on NASDAQ, with an aggregate market value of $11,500,000.00. The filing states the shares were acquired the same day (09/09/2025) via a stock option exercise and paid for in cash. The broker listed is E*TRADE from Morgan Stanley, Alpharetta, GA.

The filer also disclosed three recent sales by James A. Clark in late August 2025 totaling 73,726 shares for gross proceeds of $1,696,856.00 across three dates (08/25/2025–08/27/2025). The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Positive

• Full disclosure of proposed sale including shares, value, broker, and sale date
• Acquisition method disclosed (stock option exercise) and payment method (cash)
• Recent insider sales detailed with dates and gross proceeds, supporting transparency

Negative

• Large proposed sale of 500,000 shares valued at $11,500,000.00 could increase share supply if executed
• Recent insider disposals of 73,726 shares for $1,696,856.00 may be viewed negatively by some investors
• No explanation provided for the timing, purpose, or any trading plan adoption date in the filing

Insights

Securities Analyst

TL;DR: A significant proposed insider sale of 500,000 shares (~$11.5M) was disclosed, plus recent insider disposals totaling 73,726 shares.

The filing documents a same-day option exercise and proposed public sale, which creates immediate supply pressure if executed. The aggregate market value of the proposed sale is $11,500,000.00, and recent sales by James A. Clark totaled 73,726 shares for $1,696,856.00. For investors, the material fact is clear disclosure of insider liquidity—but the filing contains no explanation for the sales beyond the exercise and cash payment. No earnings or operational details are provided.

Corporate Governance Expert

TL;DR: The Form 144 shows compliance with disclosure rules for proposed insider sales; it does not indicate regulatory or governance violations.

The document records the required representations and a broker, and lists that the securities were acquired by stock option exercise with cash payment. The filing includes recent aggregated sales by an identified individual. There is no assertion of undisclosed material adverse information. From a governance standpoint, the filing demonstrates procedural transparency but provides no context on insider intent or any trading plan dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E*TRADE from Morgan Stanley 3 Edison Drive Alpharetta GA 30005	500000	11500000.00	30004460	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/09/2025	Stock Option Exercise	Issuer			500000	09/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Clark 10000 Alliance Road Cincinnati OH 45242	Common Stock	08/25/2025	23109	531738.00
James A. Clark 10000 Alliance Road Cincinnati OH 45242	Common Stock	08/26/2025	24020	551259.00
James A. Clark 10000 Alliance Road Cincinnati OH 45242	Common Stock	08/27/2025	26597	613859.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for LYTS disclose?

The Form 144 discloses a proposed sale of 500,000 common shares to be sold on 09/09/2025 on NASDAQ with an aggregate market value of $11,500,000.00.

How were the 500,000 LYTS shares acquired?

The shares were acquired on 09/09/2025 via a stock option exercise from the issuer, with payment made in cash on the same date.

Who is the broker handling the proposed sale of LYTS shares?

The broker listed is E*TRADE from Morgan Stanley, address shown as 3 Edison Drive, Alpharetta, GA 30005.

Were there recent sales of LYTS stock by insiders?

Yes. James A. Clark sold 23,109 shares on 08/25/2025, 24,020 shares on 08/26/2025, and 26,597 shares on 08/27/2025, totaling 73,726 shares for gross proceeds of $1,696,856.00.

Does the filing state there is undisclosed material information?

The signer represents that they do not know any material adverse information

What is the aggregate market value of the proposed LYTS sale?

The aggregate market value reported for the proposed sale is $11,500,000.00.